[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369054-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369054-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","alkbh5-mediated-m6a-demethylation-of-txndc5-drives-malignant-progression-in-gastric-cancer","ALKBH5-mediated m6A demethylation of TXNDC5 drives malignant progression in gastric cancer","","Gastric cancer remains a major cause of cancer-related death worldwide, and N6-methyladenosine (m6A) is central to post-transcriptional gene regulation. This study investigated how the RNA demethylase ALKBH5 controls GC progression through m6A modification of TXNDC5. Using ALKBH5/TXNDC5 gain- and loss-of-function in GC cells, MeRIP-qPCR, qPCR, and Western blot assessed m6A status and TXNDC5 expression. Functional assays and xenograft experiments evaluated proliferation, migration, invasion, and tumor growth. Results showed ALKBH5 upregulation stabilizes TXNDC5 expression in an m6A-dependent manner, promoting malignant phenotypes, while ALKBH5 knockdown reduced TXNDC5 and suppressed malignant behaviors, confirming an ALKBH5-TXNDC5 axis as a therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/alkbh5-mediated-m6a-demethylation-of-txndc5-drives-malignant-progression-in-gastric-cancer/369054/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/alkbh5-mediated-m6a-demethylation-of-txndc5-drives-malignant-progression-in-gastric-cancer/369054.png","ImageObject",300,407,{"name":42,"@type":43},"CatatanPagi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does ALKBH5 play in gastric cancer progression?","Question",{"text":63,"@type":64},"ALKBH5 is upregulated in gastric cancer tissues and cells and promotes malignant progression by stabilizing TXNDC5 through m6A-dependent regulation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does ALKBH5 affect m6A modification of TXNDC5?",{"text":68,"@type":64},"ALKBH5 overexpression stabilizes TXNDC5 in an m6A-dependent manner, while ALKBH5 knockdown increases m6A methylation of TXNDC5 and reduces TXNDC5 protein expression.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence supports the ALKBH5–TXNDC5 axis as a potential therapeutic target?",{"text":72,"@type":64},"Cell-based functional assays show changes in proliferation, migration, and invasion after ALKBH5 manipulation, and xenograft experiments confirm that loss of ALKBH5 impairs tumor growth.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369054,1790615542,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","EPIGENOMICS  \n2026, VOL. 18, NO. 1, 15–26  \n[https://doi.org/10.1080/1750191](https://doi.org/10.1080/1750191)1.2025.2586450  \n| RESEARCH ARTICLE   \u003Cbr>ALKBH5-mediated m6A demethylation of TXNDC5 drives malignant progression in gastric cancer\u003Cbr>Wenkun Penga*, Xiaoquan Weib*, Feifei Zhoua and Hongwei Xua\u003Cbr>aDepartment of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China; bDepartment of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, China |  |  |\n| --- | --- | --- |\n| ABSTRACT\u003Cbr>Background: Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide. N6-methyladenosine (m6A) modification plays a critical role in post-transcriptional gene regulation. This study aimed to elucidate the molecular mechanism by which the RNA demethylase ALKBH5 regulates GC progression through m6A modification of thioredoxin domain-containing protein 5 (TXNDC5) . Methods: Differential expression models of ALKBH5 and TXNDC5 were established in GC cells using RNA interference and gene overexpression. Methylated RNA immunoprecipitation (MeRIP-qPCR), qPCR, and Western blot were performed to assess ALKBH5-mediated m6A modification and its effect on TXNDC5 expression. Functional assays, including proliferation, migration, and invasion, as well asa xenograft mouse model, were used to evaluate their roles in GC progression.\u003Cbr>Results: ALKBH5 was significantly upregulated in GC tissues and cells. Overexpression of ALKBH5 stabilized TXNDC5 expression in an m6A-dependent manner, thereby promoting malignant phenotypes. Conversely, ALKBH5 knockdown increased m6A methylation of TXNDC5, reduced TXNDC5 protein expression, and suppressed GC cell proliferation, migration, and invasion. In vivo experiments confirmed that loss of ALKBH5 impaired tumor growth.\u003Cbr>Conclusions: Our findings demonstrate that the ALKBH5–TXNDC5 axis drives GC progression through m6A-dependent regulation, highlighting ALKBH5 as a potential therapeutic target for GC.\u003Cbr>PLAIN LANGUAGE SUMMARY\u003Cbr>Stomach cancer is a serious disease that is often hard to treat. In this study, we focused on a protein called ALKBH5, which helps cancer cells grow. We found that ALKBH5 increases the level of another protein, TXNDC5, making stomach cancer cells stronger and more likely to spread. When ALKBH5 was blocked, TXNDC5 decreased, and the cancer cells became weaker. These results show that ALKBH5 May drive stomach cancer growth and could be a new target for treatment in the future. |  | ARTICLE HISTORY\u003Cbr>Received 5 May 2025\u003Cbr>Accepted 3 November 2025\u003Cbr>KEYWORDS\u003Cbr>TXNDC5; gastric cancer; ALKBH5; m6A; posttranscriptional modification |\n| 1. Introduction\u003Cbr>Gastric cancer, a malignancy of significant global health concern, is characterized by an annual incidence exceeding 1 million cases and approximately 760,000 deaths worldwide. Though advancements in clinical interventions and populationlevel prevention strategies have driven a progressive decline in both morbidity and mortality rates, GC persists as the fifth most prevalent neoplasm globally and ranks third among cancerrelated fatalities [1–4]. This persistent burden predominantly stems from three interrelated factors: diagnostic delays caused by nonspecific early symptomatology; aggressive tumor biology marked by rapid progression and high metastatic potential at initial presentation [5]. The pathogenesis of GC involves a multifactorial interplay between environmental exposuresand genetic susceptibility. Notably, Helicobacter pylori infection synergizes with dietary risk factors (e.g., high-salt diets, carcinogen-containing preserved foods), tobacco use, and excessive alcohol consumption to drive malignant transformation. Complementing these exogenous risks, hereditary | predisposition and premalignant conditions (notably chronic atrophic gastritis and gastric intestinal metaplasia) further ampli","cbCaikETSdL7bgmt","https://ap.wps.com/l/cbCaikETSdL7bgmt","pdf",13777583,12,"English","# Abstract\n# Introduction\n# Methods and Experiments (MeRIP-qPCR, qPCR, Western blot, Functional assays, Xenografts)\n# Results\n## ALKBH5 upregulates and stabilizes TXNDC5 via m6A\n## ALKBH5 knockdown suppresses malignant phenotypes in vitro and in vivo\n# Conclusions","[{\"question\":\"What role does ALKBH5 play in gastric cancer progression?\",\"answer\":\"ALKBH5 is upregulated in gastric cancer tissues and cells and promotes malignant progression by stabilizing TXNDC5 through m6A-dependent regulation.\"},{\"question\":\"How does ALKBH5 affect m6A modification of TXNDC5?\",\"answer\":\"ALKBH5 overexpression stabilizes TXNDC5 in an m6A-dependent manner, while ALKBH5 knockdown increases m6A methylation of TXNDC5 and reduces TXNDC5 protein expression.\"},{\"question\":\"What evidence supports the ALKBH5–TXNDC5 axis as a potential therapeutic target?\",\"answer\":\"Cell-based functional assays show changes in proliferation, migration, and invasion after ALKBH5 manipulation, and xenograft experiments confirm that loss of ALKBH5 impairs tumor growth.\"}]","ALKBH5-mediated m6A demethylation of TXNDC5 drives malignant progression in gastric cancer | PDF",1790180378,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/31bd6c41cc0423b7938079d58f135b8a.webp",983,1280,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/58c17eecf74a7b378373bcddd0c7c047.webp",982,1278,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65137a7013ced6cbc26d79ba6b466d31.webp",981,1277,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3be7d2cb5d9e457c669e1f864f66cea.webp",980,1276]